Steve Jobs’ son, Healthmap lead this week’s digital health funding

Must read

Steve Jobs’ son launches $200M fund on cancer care 

Reed Jobs, the son of deceased Apple co-founder Steve Jobs, is starting an investment fund that will focus on cancer care. 

The fund, named Yosemite, will invest in therapeutics, diagnostics and digital health around the oncology ecosystem. The company will fund early-stage companies and provide grants to emerging research. 

Yosemite spun out from Emerson Collective Health, which was founded by Steve Jobs’ widow, Laurene Powell Jobs. It will manage Emerson Collective Health’s legacy portfolio as an investment advisor

Among its early investments are Teal Health, a women’s health startup; TrialSpark, a clinical trial company and Apropos, a patient data company. The venture fund’s limited partners include New York City-based Memorial Sloan Kettering Cancer Center and venture capital investor John Doerr. 

Steve Jobs died of pancreatic cancer in 2011. 

Kidney care-focused Healthmap Solutions closes $100M round

Healthmap Solutions, a population health company focused on kidney care, raised an undisclosed $100 million funding round.

The Tampa, Florida-based company said it will use the funding to expand its business and grow the number of patients covered under capitated arrangements. The company said it is contracted to around 160,000 patients with kidney disease.

Private equity company WindRose Health Investors led the round with support from the company’s existing investors. The company raised $35 million in May 2022.

It’s been an eventful year for digital health companies in the kidney care space. Strive Health, a digital health company focused on kidney care, closed a $166 million Series C funding round in May while Monogram Health raised $375 million.

Cleveland Clinic-backed Enspire DBS Therapy nabs $17.6M Series B

The company is developing an implantable neuromodulation therapy for patients in post-stroke recovery. The round was led by Cleveland Clinic, an existing investor. (Enspire DBS is a Clinic portfolio company.) Also participating in the round were JobsOhio Growth Capital Fund and an undisclosed investor, Enspire DBS said in a news release. 

Uptiv Health nabs $7.5M, opens first physical location

Uptiv Health, a hybrid infusion treatment company, closed a $7.5 million seed round Wednesday. The company said it will open its first physical location based in Westland, Michigan at the end of August.

Uptiv’s model seeks to bridge the gap between the convince of at-home infusion therapy treatments with the benefits of in-person treatments. In-home infusion therapy has seen an increase in usage as a way to treat chronic illnesses such as cancer, cancer-related pain, hemophilia, immune deficiencies, Crohn’s disease, rheumatoid arthritis and multiple sclerosis.

The company, which received funding from healthcare startup creator Redesign Health, plans additional in-person clinic locations “in the near future.” 

MemorialCare Health System helps fund TytoCare 

TytoCare, a virtual care company, closed a $49 million funding round Thursday.

TytoCare has developed a remote examination device that helps patients manage chronic conditions. The company will use the funding to develop new uses of artificial intelligence in diagnostic support and remote examination assistance. The round brings the company’s total funding to $205 million to date. 

Insight Partners, a technology venture capital firm, led the round with support from California-based MemorialCare Health System and Healthcare of Ontario Pension Plan. 

More articles

Latest article